Prevalence of KRAS and Concomitant Mutations in Advanced Lung Adenocarcinoma Patients

被引:0
|
作者
Gil Ferreira, C. [1 ]
Montella, T. [1 ]
Moreira De Sousa, C. [2 ]
Zalis, M. [3 ]
Aran, V. [4 ]
机构
[1] Oncoclinicas, Rio De Janeiro, Brazil
[2] Univ Estado Rio Janeiro Uerj, Fac Ciencias Med Fcm, Dept Tecnol Informacao & Educ Saude Dties, Rio De Janeiro, Brazil
[3] Oncoclinicas, Sao Paulo, Brazil
[4] Inst Estadual Cerebro Paulo Niemeyer, Rio De Janeiro, Brazil
关键词
advanced lung adenocarcinoma; concomitant mutations; KRAS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P70.10
引用
收藏
页码:S1214 / S1214
页数:1
相关论文
共 50 条
  • [1] Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients
    Aran, Veronica
    Zalis, Mariano
    Montella, Tatiane
    de Sousa, Carlos Augusto Moreira
    Ferrari, Bruno L.
    Gil Ferreira, Carlos
    MEDICINA-LITHUANIA, 2021, 57 (10):
  • [2] Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma
    Johnson, M. L.
    Sima, C.
    Paik, P. K.
    Janjigian, Y. Y.
    Pao, W.
    Kris, M. G.
    Ladanyi, M.
    Riely, G. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma
    Gibert, Joan
    Clave, Sergi
    Hardy-Werbin, Max
    Taus, Alvaro
    o Rocha, Pedr
    Longaron, Raquel
    Piquer, Gabriel
    Chaib, Imane
    Carcereny, Enric
    Moran, Teresa
    Salido, Marta
    Dalmases, Alba
    Bellosillo, Beatriz
    Arriola, Edurne
    LUNG CANCER, 2020, 140 : 42 - 45
  • [4] Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report
    Iaccarino, Antonino
    Pisapia, Pasquale
    De Felice, Marco
    Pepe, Francesco
    Gragnano, Gianluca
    De Luca, Caterina
    Ianniello, Giovanni
    Malapelle, Umberto
    JOURNAL OF MOLECULAR PATHOLOGY, 2020, 1 (01): : 36 - 42
  • [5] KRAS mutations in 1355 Italian patients with lung adenocarcinoma
    Paliogiannis, P.
    Lobrano, R.
    Colombino, M.
    Sini, M. C.
    Fara, A.
    Fedeli, M. A.
    Palmieri, G.
    Cossu, A.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S141 - S142
  • [6] CLINICOPATHOLOGICAL FEATURES OF LUNG ADENOCARCINOMA WITH KRAS MUTATIONS
    Kakegawa, Seiichi
    Shimizu, Kimihiro
    Nakano, Tetsuhiro
    Sugano, Masayuki
    Miyamae, Yohei
    Kamiyoshihara, Mitsuhiro
    Kawashima, Osamu
    Takeyoshi, Izumi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S986 - S986
  • [7] KRAS and EGFR mutations coexisting in lung adenocarcinoma
    Vitor Sousa
    Ana Alarcão
    Patricia Couceiro
    Maria R Silva
    Maria J d’Aguiar
    Lia Teixeira
    Lina Carvalho
    BMC Proceedings, 4 (Suppl 2)
  • [8] Clinicopathological Features of Lung Adenocarcinoma With KRAS Mutations
    Kakegawa, Seiichi
    Shimizu, Kimihiro
    Sugano, Masayuki
    Miyamae, Yohei
    Kaira, Kyoichi
    Araki, Takuya
    Nakano, Tetsuhiro
    Kamiyoshihara, Mitsuhiro
    Kawashima, Osamu
    Takeyoshi, Izumi
    CANCER, 2011, 117 (18) : 4257 - 4266
  • [9] High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis
    Thomas, Anish
    Chen, Yuanbin
    Steinberg, Seth M.
    Luo, Ji
    Pack, Svetlana
    Raffeld, Mark
    Abdullaev, Zied
    Alewine, Christine
    Rajan, Arun
    Giaccone, Giuseppe
    Pastan, Ira
    Miettinen, Markku
    Hassan, Raffit
    ONCOTARGET, 2015, 6 (13) : 11694 - 11702
  • [10] EGFR Mutations in Asian Patients with Advanced Lung Adenocarcinoma
    Liam, Chong-Kin
    Pang, Yong-Kek
    Poh, Mau-Ern
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : E70 - E71